Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Harvard Medical School
March 2nd, 2026
Researchers in Andrew Kruse’s lab overcame a key obstacle in using the hormone relaxin as a therapy for heart disease. With support from Harvard’s Blavatnik Biomedical Accelerator, this discovery led to the launch of Tectonic Therapeutic, which is now testing its relaxin-based drug in clinical trials.
August 6th, 2025
New research out of Harvard Medical School suggests that lithium deficiency may be a key driver of Alzheimer’s disease and a promising target for early diagnosis and treatment. Harvard’s Office of Technology Development has protected the innovations related to this research and is actively seeking industry partners for commercialization to advance these discoveries.
April 15th, 2025
With funding and business development support from the Blavatnik Biomedical Accelerator, a research team’s lab discovery propelled to startup success.
February 7th, 2025
The team that performed first-of-its-kind surgery in 2024 has successfully transplanted another genetically edited pig kidney into a living person.
January 24th, 2025
Scientists zoom in on microbial messages at the molecular level to understand how the microbiome shapes health.
